Giant-cell tumor of bone: treatment options and role of denosumab

por Singh, Arun S, Chawla, Neal S, Chawla, Sant P
Publicado 2015

Cytoreductive Nephrectomy in 2021: Obsolete

por Meza, Luis, Chawla, Neal S., Giannarini, Gianluca, Pal, Sumanta K.
Publicado 2021

Trabectedin for Soft Tissue Sarcoma: Current Status and Future Perspectives

por Gordon, Erlinda M., Sankhala, K. Kumar, Chawla, Neal, Chawla, Sant P.
Publicado 2016

An Update on the Treatment of Papillary Renal Cell Carcinoma

por Chawla, Neal S., Sayegh, Nicolas, Prajapati, Sweta, Chan, Elyse, Pal, Sumanta K., Chehrazi-Raffle, Alexander
Publicado 2023

Knowledge translation of the American College of Emergency Physicians’ clinical policy on syncope using computerized clinical decision support

por Melnick, Edward R., Genes, Nicholas G., Chawla, Neal K., Akerman, Meredith, Baumlin, Kevin M., Jagoda, Andy
Publicado 2010

Reducing Catheter-Associated Urinary Tract Infections Across a Hospital System Through Urine Culture Stewardship

por Kalorin, Carmin M., Dixon, Jessica M., Fike, Lucy V., Paul, J. West, Chawla, Neal K., Kirk, David, Woltz, Patricia C., Stone, Nimalie D.
Publicado 2022

Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California

por Salgia, Nicholas J., Chehrazi‐Raffle, Alexander, Hsu, JoAnn, Zengin, Zeynep, Salgia, Sabrina, Chawla, Neal S., Meza, Luis, Malhotra, Jasnoor, Dizman, Nazli, Muddasani, Ramya, Ruel, Nora, Cianfrocca, Mary, Gong, Jun, Anand, Sidharth, Chiu, Victor, Yeh, James, Pal, Sumanta K.
Publicado 2021

Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles

por Govindarajan, Ameish, Salgia, Nicholas J., Li, Haiqing, Castro, Daniela V., Mirzapoiazova, Tamara, Armstrong, Brian, Zhao, Dan, Mercier, Benjamin D., Dizman, Nazli, Chawla, Neal, Zengin, Zeynep, Meza, Luis, Tripathi, Nishita, Sayegh, Nicolas, Chehrazi-Raffle, Alex, Tripathi, Abhishek, Pal, Sumanta K.
Publicado 2023

The impact of insurance status on progression-free survival (PFS) and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

por Castro, Daniela, Tripathi, Nishita, Sayegh, Nicolas, Gebrael, Georges, Li, Xiaochen, Meza, Luis, Zengin, Zeynep, Chehrazi-Raffle, Alex, Govindarajan, Ameish, Dizman, Nazli, Ebrahimi, Hedyeh, Chawla, Neal, Mercier, Benjamin, Hsu BS, JoAnn, Shi, Jessica, Philip, Errol, Bergerot, Cristiane, Barragan-Carrillo, Regina, Pal, Sumanta
Publicado 2023

Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma

por Chehrazi-Raffle, Alexander, Muddasani, Ramya, Dizman, Nazli, Hsu, JoAnn, Meza, Luis, Zengin, Zeynep B., Malhotra, Jasnoor, Chawla, Neal, Dorff, Tanya, Contente-Cuomo, Tania, Dinwiddie, Devin, McDonald, Bradon R., McDaniel, Timothy, Trent, Jeffrey M., Baehner, Frederick L., Murtaza, Muhammed, Pal, Sumanta K.
Publicado 2023

CT-based radiomics model for the prediction of genomic alterations in renal cell carcinoma (RCC)

por Ebrahimi, Hedyeh, Lu, Kun-Han, Castro, Daniela V, Mercier, Benjamin D, Dizman, Nazli, Barragan-Carrillo, Regina, Govindarajan, Ameish, Meza, Luis, Chawla, Neal S, Hsu, JoAnn, Chehrazi-Raffle, Alexander, Tripathi, Abhishek, Liu, Sandy, Dorff, Tanya B, Wah Wong, Chi, Pal, Sumanta K, Zengin, Zeynep B
Publicado 2023

Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis

por Meza, Luis, Zengin, Zeynep, Salgia, Sabrina, Malhotra, Jasnoor, Karczewska, Ewa, Dorff, Tanya, Tripathi, Abhishek, Ely, Jennifer, Kelley, Erin, Mead, Heather, Hsu, JoAnn, Dizman, Nazli, Salgia, Nicholas, Chawla, Neal, Chehrazi-Raffle, Alex, Muddasani, Ramya, Govindarajan, Ameish, Rock, Adam, Liu, Sandy, Salgia, Ravi, Trent, Jeffrey, Altin, John, Pal, Sumanta K
Publicado 2023

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

por Dizman, Nazli, Meza, Luis, Bergerot, Paulo, Alcantara, Marice, Dorff, Tanya, Lyou, Yung, Frankel, Paul, Cui, Yujie, Mira, Valerie, Llamas, Marian, Hsu, Joann, Zengin, Zeynep, Salgia, Nicholas, Salgia, Sabrina, Malhotra, Jasnoor, Chawla, Neal, Chehrazi-Raffle, Alex, Muddasani, Ramya, Gillece, John, Reining, Lauren, Trent, Jeff, Takahashi, Motomichi, Oka, Kentaro, Higashi, Seiya, Kortylewski, Marcin, Highlander, Sarah K., Pal, Sumanta K.
Publicado 2022